SLC10A2 and Alagille syndrome: In keeping with this observation, ileal bile acid transporter (IBAT) inhibitors, have been proposed for the treatment of patients with PFIC and Alagille syndrome, and approved in mid-2021 to treat intractable pruritus related to cholestasis [72,73,74].